Multi-component Intervention for Diabetes in Adults with Serious Mental Illness (MIDAS)
针对患有严重精神疾病的成人糖尿病的多成分干预 (MIDAS)
基本信息
- 批准号:10063409
- 负责人:
- 金额:$ 18.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAgingAudiotapeBehaviorBehavioral MechanismsBiological AgingBiological MarkersBipolar DisorderBloodBody mass indexC-reactive proteinCaliforniaCardiovascular DiseasesCaringClinicalCommunity PracticeCountyDataDiabetes MellitusDiabetic DietDietDiet ModificationDietary InterventionEducationEffectivenessEffectiveness of InterventionsEnvironmentEvidence based interventionExerciseFutureGeneral PopulationGlycosylated hemoglobin AGoalsHealthHousingHybridsIndividualInflammationInflammatoryInsulin ResistanceInsuranceInterventionKnowledgeLeadLicensingLife StyleLiteratureLongevityMeasuresMediatingMedicalMetabolicModalityModelingModificationNational Institute of Mental HealthNon-Insulin-Dependent Diabetes MellitusOutcomeOutcome MeasureParticipantPatientsPersonsPhasePhysical activityPremature MortalityProcessRandomizedResearchResearch PersonnelRiskRisk FactorsRisk ReductionSchizoaffective DisordersSchizophreniaSelf EfficacySiteSmokingTestingTrainingWorkbasebehavior changeburnoutcigarette smokingcohortcomorbiditycookingcostdiabetes managementdiabetes riskeffectiveness implementation studyevidence basefasting glucosefollow-upgroup interventionhigh riskhigh risk populationimplementation strategyinnovationlifestyle interventionmembermortalitymulti-component interventionmultimodalitynovelobesogenicpatient home carepost interventionpractice settingprematurepreventprimary outcomeresidential care facilitysedentary lifestylesevere mental illnesssexsmoking cessationsuccessful interventiontrial designunhealthy lifestylewaist circumference
项目摘要
Project Summary/Abstract
Serious mental illnesses (SMI), including schizophrenia, bipolar disorder, and schizoaffective disorder, are
associated with increased medical comorbidity and premature mortality from diabetes and cardiovascular
disease. Unhealthy lifestyles, including energy-dense (obesogenic) diet, sedentary behavior, and cigarette
smoking are important risk factors for diabetes and accelerated biological aging. All of these risk factors are
potentially modifiable. There is considerable literature documenting the effectiveness of strategies to prevent
and manage diabetes in the general population; yet, these interventions are rarely offered to people with SMI.
Residential Care Facilities (RCFs), called Board-and-Care Homes in California, are a common housing
modality for patients with SMI; they provide a venue that can maximize efficiency and sustainability of a
lifestyle intervention. The goals of the proposed four-year study are to tailor a multi-component intervention to
this high-risk group. The study will be a hybrid effectiveness-implementation (Hybrid Type 1) trial of a Multi-
component Intervention for Diabetes risk reduction in Adults with SMI (MIDAS) in licensed RCFs in San Diego
county. As a Hybrid Type 1 study, the primary emphasis will be on determining the effectiveness of the
intervention to achieve desired health outcomes while also systematically collecting data on its implementation
within RCFs that will inform implementation strategy refinement. Main components of MIDAS include: (1)
Education about diabetes and lifestyle, (2) Dietary intervention at the facility and resident level, (3) Increased
physical activity, and (4) Smoking cessation / reduction. We will employ a modified cluster-randomized stepped
wedge and adaptive trial design involving 210 residents with SMI and 120 staff members from 12 RCFs. The
RCFs will be divided randomly into four cohorts of three RCFs each. Each cohort will be tested over a 15-
month period that includes three phases: a three-month initial control phase (no intervention, from baseline
month 0 to end of month 3), a six-month intervention phase (months 4 through 9), and a six-month follow-up
phase (no intervention, months 10 through 15). All the study participants will be assessed quarterly during the
15-month period. Our investigators will train RCF staff (especially the Activity Director and cook) to increase
physical activity and reduce smoking, and to implement healthful dietary modifications among the residents,
using evidence-based interventions. During the intervention phase, the RCF Activity Director will conduct
twice-weekly manualized group sessions on education about diabetes, nutrition, exercise, and smoking
cessation/reduction, to deliver a multi-component group intervention. We will also explore if there are
improvements in blood-based research biomarkers of insulin resistance and inflammation in the RCF residents
with SMI. This project is responsive to RFA-MH-17-608, and related to NIMH Strategic Objective #3.3B: testing
interventions for effectiveness in community practice settings. If successful, MIDAS will be sustained and
disseminated, and would lead to reduction in excess medical comorbidity and mortality associated with SMI.
项目总结/摘要
严重精神疾病(SMI),包括精神分裂症、双相情感障碍和情感障碍,
与糖尿病和心血管疾病的合并症和过早死亡率增加有关
疾病不健康的生活方式,包括高能量(肥胖)饮食,久坐不动的行为和吸烟
吸烟是糖尿病和加速生物衰老的重要危险因素。所有这些风险因素都是
可能是可修改的。有大量文献记载了预防战略的有效性,
并管理一般人群的糖尿病;然而,这些干预措施很少提供给SMI患者。
住宅护理设施(RCF),在加州称为寄宿和护理之家,是一种常见的住房
模式与SMI患者;他们提供了一个场所,可以最大限度地提高效率和可持续性的
生活方式干预拟议的四年研究的目标是量身定制一个多组成部分的干预,
这个高危人群。本研究将是一项混合有效性-实施(混合1型)试验,
在圣地亚哥有执照的RCF中,对成年SMI患者(MIDAS)进行糖尿病风险降低干预
县作为混合1型研究,主要重点是确定
采取干预措施,以实现预期的健康成果,同时系统地收集有关实施情况的数据,
在区域合作框架内,这将为实施战略的完善提供信息。MIDAS的主要组成部分包括:(1)
关于糖尿病和生活方式的教育,(2)在设施和居民层面的饮食干预,(3)增加
(4)戒烟/戒烟。我们将采用一个修改的集群随机步进
楔形和适应性试验设计,涉及210名患有SMI的居民和来自12个RCF的120名工作人员。的
RCF将随机分为4个队列,每个队列3个RCF。每个队列将在15-
一个月的时间,包括三个阶段:三个月的初始控制阶段(无干预,从基线
第0个月至第3个月结束)、6个月干预阶段(第4个月至第9个月)和6个月随访
阶段(无干预,10 - 15个月)。所有研究参与者将在研究期间接受季度评估。
15-月期间。我们的调查人员将培训RCF工作人员(特别是活动总监和厨师),
体育活动和减少吸烟,并在居民中实施健康的饮食调整,
使用基于证据的干预措施。在干预阶段,区域合作框架活动主任将
每周两次关于糖尿病、营养、锻炼和吸烟教育的手册化小组会议
停止/减少,以提供一个多组成部分的群体干预。我们还将探讨是否有
RCF居民胰岛素抵抗和炎症的血液研究生物标志物的改善
关于SMI本项目响应RFA-MH-17 - 608,并与NIMH战略目标#3.3B:测试相关
在社区实践环境中进行有效干预。如果取得成功,将维持MIDAS,
扩散,并将导致减少与SMI相关的过度医疗并发症和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DILIP V. JESTE其他文献
DILIP V. JESTE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DILIP V. JESTE', 18)}}的其他基金
Sustained Training in Aging and HIV Research (STAHR)
老龄化和艾滋病毒研究持续培训(STAHR)
- 批准号:
9140529 - 财政年份:2016
- 资助金额:
$ 18.97万 - 项目类别:
Sustained Training in Aging and HIV Research (STAHR)
老龄化和艾滋病毒研究持续培训(STAHR)
- 批准号:
9251916 - 财政年份:2016
- 资助金额:
$ 18.97万 - 项目类别:
Sustained Training in Aging and HIV Research (STAHR)
老龄化和艾滋病毒研究持续培训(STAHR)
- 批准号:
9888426 - 财政年份:2016
- 资助金额:
$ 18.97万 - 项目类别:
Multi-Dimensional Successful Aging Among HIV-Infected Adults
艾滋病毒感染者的多维成功老龄化
- 批准号:
9248156 - 财政年份:2016
- 资助金额:
$ 18.97万 - 项目类别:
Multi-Dimensional Successful Aging Among HIV-Infected Adults
艾滋病毒感染者的多维成功老龄化
- 批准号:
8466529 - 财政年份:2013
- 资助金额:
$ 18.97万 - 项目类别:
Multi-Dimensional Successful Aging Among HIV-Infected Adults
艾滋病毒感染者的多维成功老龄化
- 批准号:
8787283 - 财政年份:2013
- 资助金额:
$ 18.97万 - 项目类别:
Multi-Dimensional Successful Aging Among HIV-Infected Adults
艾滋病毒感染者的多维成功老龄化
- 批准号:
9901981 - 财政年份:2013
- 资助金额:
$ 18.97万 - 项目类别:
Multi-Dimensional Successful Aging Among HIV-Infected Adults
艾滋病毒感染者的多维成功老龄化
- 批准号:
8990889 - 财政年份:2013
- 资助金额:
$ 18.97万 - 项目类别:
Multi-Dimensional Successful Aging Among HIV-Infected Adults
艾滋病毒感染者的多维成功老龄化
- 批准号:
9195747 - 财政年份:2013
- 资助金额:
$ 18.97万 - 项目类别:
Multi-Dimensional Successful Aging Among HIV-Infected Adults
艾滋病毒感染者的多维成功老龄化
- 批准号:
8604174 - 财政年份:2013
- 资助金额:
$ 18.97万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 18.97万 - 项目类别:
Operating Grants














{{item.name}}会员




